EDGAR Filing Documents for 0001193125-12-337971

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-12-337971

Filing Date

2012-08-06

Accepted

2012-08-06 17:02:15

Documents

Period of Report

2012-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d356988d10q.htm	10-Q	755385
2	AMENDMENT NO.1 TO EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS AGREEMENT	d356988dex109iv.htm	EX-10.9(IV)	97453
3	LETTER AGREEMENT BETWEEN THE COMPANY AND JOHN OSBORN	d356988dex1023.htm	EX-10.23	20220
4	CERTIFICATION OF CEO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A)	d356988dex311.htm	EX-31.1	8740
5	CERTIFICATION OF CFO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A)	d356988dex312.htm	EX-31.2	8796
6	CERTIFICATIONS AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B)	d356988dex321.htm	EX-32.1	4887
13	GRAPHIC	g356988g07y23.jpg	GRAPHIC	4113
	Complete submission text file	0001193125-12-337971.txt		5218636

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	onxx-20120630.xml	EX-101.INS	754062
8	XBRL TAXONOMY EXTENSION SCHEMA	onxx-20120630.xsd	EX-101.SCH	42015
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	onxx-20120630_cal.xml	EX-101.CAL	66591
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	onxx-20120630_def.xml	EX-101.DEF	114750
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	onxx-20120630_lab.xml	EX-101.LAB	335071
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	onxx-20120630_pre.xml	EX-101.PRE	261200

Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080

Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000

ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)